Literature DB >> 31394282

Resistance Training Increases Muscle Strength and Muscle Size in Patients With Liver Cirrhosis.

Luise Aamann1, Gitte Dam2, Mette Borre2, Aska Drljevic-Nielsen3, Kristian Overgaard4, Henning Andersen5, Hendrik Vilstrup2, Niels Kristian Aagaard2.   

Abstract

BACKGROUND & AIMS: Cirrhosis is often complicated by reduced muscle mass and strength, which limits the ability to perform daily activities and affects quality of life. Resistance training can increase muscle strength and mass in elderly and chronically ill patients. We performed a randomized controlled trial to investigate whether resistance training increases muscle strength and size in patients with compensated cirrhosis.
METHODS: We performed a prospective study of 39 patients with cirrhosis (Child-Pugh class A or B) seen at an outpatient clinic in Denmark from January 2015 through March 2017. Participants protein intake and activity levels were registered daily. Participants were randomly assigned (1:1) to a group that performed 36 1-hour sessions of physical exercise (supervised progressive resistance training for 1 hour, 3 times weekly for 12 weeks) or a control group (no change in daily activity level). Maximal muscle strength was measured as the peak torque in isokinetic knee extension and muscle size was measured as the cross-sectional area of the quadriceps muscle, assessed by magnetic resonance imaging of the thigh.
RESULTS: The exercise group increased their muscle strength by 13% (from a mean 119 Nm to 134 Nm)-an 11 Nm greater gain in mean strength than that of the control group (P = .05). The exercise group increased their quadriceps cross-sectional area by 10% (from a mean 58.5 cm2 to 64.6 cm2)-a 4.4 cm2 greater gain than that of the control group (P < .01). The exercise group had significant increases in whole-body lean mass and body cell mass, and significant increases in 6-minute walking distance and the mental component summary of the short form-36 questionnaire. Adverse events were minor and equal between groups.
CONCLUSIONS: In a randomized trial of patients with compensated cirrhosis, we found that 12 weeks of supervised progressive resistance training increased muscle strength and size and had beneficial effects on general performance measures, compared with patients who did not change their daily activity routine (control subjects). ClinicalTrials.gov no: NCT02343653.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic Liver Disease; Exercise; Malnutrition; Quality of Life; Sarcopenia

Year:  2019        PMID: 31394282     DOI: 10.1016/j.cgh.2019.07.058

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  14 in total

1.  Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Andrea Gonzalez; Mayalen Valero-Breton; Camila Huerta-Salgado; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2021-03-26

Review 2.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

3.  Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis.

Authors:  Andrew M Moon; Yue Jiang; Shari S Rogal; Elliot B Tapper; Sarah R Lieber; A Sidney Barritt
Journal:  Aliment Pharmacol Ther       Date:  2020-01-21       Impact factor: 8.171

4.  Resistance Training Reduces Risk of Sarcopenia in Patients With Cirrhosis.

Authors:  Puneeta Tandon; Michael A Dunn; Andres Duarte-Rojo
Journal:  Clin Gastroenterol Hepatol       Date:  2019-10-04       Impact factor: 11.382

Review 5.  Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions.

Authors:  Abhilash Perisetti; Hemant Goyal; Rachana Yendala; Saurabh Chandan; Benjamin Tharian; Ragesh Babu Thandassery
Journal:  World J Gastroenterol       Date:  2022-01-28       Impact factor: 5.742

6.  Aerobic Exercise Attenuates Pressure Overload-Induced Cardiac Dysfunction through Promoting Skeletal Muscle Microcirculation and Increasing Muscle Mass.

Authors:  Ling-Yan Yuan; Pei-Zhao Du; Min-Min Wei; Qi Zhang; Le Lu; Xu Tian; Shao-Ting Fu; Xiao-Li Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-15       Impact factor: 2.629

7.  Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jennifer C Lai; Puneeta Tandon; William Bernal; Elliot B Tapper; Udeme Ekong; Srinivasan Dasarathy; Elizabeth J Carey
Journal:  Hepatology       Date:  2021-09       Impact factor: 17.298

8.  Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis.

Authors:  Tatsunori Hanai; Makoto Shiraki; Kenji Imai; Atsushi Suetsugu; Koji Takai; Masahito Shimizu
Journal:  J Clin Med       Date:  2020-04-03       Impact factor: 4.241

Review 9.  Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments.

Authors:  Giovanni Marasco; Matteo Serenari; Matteo Renzulli; Luigina Vanessa Alemanni; Benedetta Rossini; Irene Pettinari; Elton Dajti; Federico Ravaioli; Rita Golfieri; Matteo Cescon; Davide Festi; Antonio Colecchia
Journal:  J Gastroenterol       Date:  2020-08-03       Impact factor: 7.527

10.  The efficacy of parenteral nutrition (PN) and enteral nutrition (EN) supports in cirrhosis: A systematic review and network meta-analysis.

Authors:  Bin Yu; Jiting Wang
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.